Clinical Trial: Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549295) titled 'Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)' on March 09.

Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of melatonin in the treatment of early-onset severe maternal vascular malperfusion-related fetal growth restriction (MVM-FGR), and to determine its effects on fetal growth and perinatal outcomes. The study will enroll pregnant women with singleton pregnancies diagnosed with severe MVM-FGR between 24+0 and 31+6 weeks of gestation.

The main questions it aims to answer are:

* Whether melatonin treatment can reduce the incidence of a composite adverse n...